Juan Carlos Cardet, MD
Allergy & Immunology · Tampa, FLNPI 1003071713
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $133,443 of the $179,995 with a category attached, or 74.1%. 22 manufacturers reported payments, led by Sanofi at 29.1% of the total. 2025 is the largest year on record at $71,756, more than ten times the $272 reported in 2019. Among allergy & immunology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $891.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$52K
- GSK$46K
- AstraZeneca$45K
- Chiesi USA, Inc.$18K
- Genentech USA, Inc.$7K
- Regeneron Healthcare Solutions, Inc.$4K
- plus $7K from 16 others
Across 5 payments — averaging $57,641 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$288K
What the payments were for
- Consulting fees$133,44374%
- Speaking & faculty fees$22,66813%
- Grants$8,9365%
- Travel & lodging$6,7284%
- Food & beverage$8,1955%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 46 | $52,427 |
| GSK | 28 | $46,009 |
| AstraZeneca | 71 | $45,090 |
| Chiesi USA, Inc. | 6 | $17,989 |
| Genentech USA, Inc. | 13 | $7,476 |
| Regeneron Healthcare Solutions, Inc. | 5 | $4,190 |
| Amgen | 1 | $3,000 |
| Eli Lilly | 1 | $2,100 |
| Novartis | 7 | $779 |
| Regeneron | 3 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $187 |
| Genentech, Inc. | 3 | $104 |
| ADMA Biomanufacturing LLC | 1 | $97 |
| CSL Behring | 3 | $66 |
| Circassia Inc. | 2 | $55 |
| Alk-abello, Inc | 2 | $46 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 2 | $25 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Shire North American Group Inc | 1 | $16 |
| Kaleo, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$179,995 in reported general payments places this provider in the 95th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $163,988 |
| XolairOmalizumab | 12 | $66,819 |
| Dupixent PenDupilumab | 17 | $64,990 |
| Sodium Chloride0.9 % Sodium Chloride | 12 | $33 |
| Montelukast Sodium | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringPrivigen | $66 | $163,98812 claims |
| Genentech, Inc.Xolair | $104 | $66,81912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Tampa
- Dennis LedfordTampa$1.2M
- Thomas CasaleTampa$382K
- Mark GlaumTampa$337K
- Farnaz TabatabaianTampa$76K
- Seong ChoTampa$42K
- Richard LockeyTampa$27K
- Ammar HatabTampa$14K
- Richard SiegelTampa$13K
- Nina RamirezMiami$833K
- Thomas WestbrookPensacola$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.